Economist Michael Decter Lists Mettrum as a "Top Pick" on BNN's Market Call.

A recent article on BNN market Call highlighted Mettrum Health Corp. (TSXV:MT.V).

A recent article on BNN market Call highlighted Mettrum Health Corp. (TSXV:MT.V).
As quoted in the article:

Canada faces a major political challenge in determining whether there is the political will to build any pipelines in the face of determined, although not unified, opposition from environmental and Indigenous groups. For a federal government committed to rebuilding infrastructure, it is odd that oil by rail as the default choice would be acceptable.
We are in a lower-for-longer economic environment in terms of economic growth, interest rates and commodity prices. However, we expect a strong finish to 2016 in North American equity markets following the U.S. presidential election.
Top Picks
Mettrum Health (MT.V)
Mettrum has 16,000 patients and has established itself as one of, if not the, strongest medicinal players. Company has perhaps the best reputation amongst physician community.
Industry is growing at 10 per cent month-over-month and Mettrum is maintaining its market share of approximately 12 to 15 per cent.
Company is fully licensed at two facilities with limitless ability to increase capacity.
Running at 70 per cent gross margins.
Cash of over $30 million.
Well positioned to participate in recreational market, which is expected to be rolled out next year.
Company has a market cap of $150 million versus Canopy at $460 million, despite Canopy having 2,000 patients and similar operating metrics to Mettrum.
Aphria has half the patients and twice the market cap.
Handful of other new entrants with a fraction of the business of MT also trade at $150 million market cap.
Massive valuation discrepancy between MT and the other players.
Starting to think this space if getting a bit ahead of itself, but Mettrum continues to look like exceptional value and the best way to play the space.